Dr. Bharadwaj Ponnada
Specialist Medical Oncology
Medical Oncology
MBBS, MD (Internal Medicine), DM (Medical Oncology)
About Dr. Bharadwaj Ponnada
Dr. Bharadwaj Ponnada is a Specialist in Medical Oncology who completed his DM at Amrita Institute of Medical Sciences, Kerala, one of India's most respected medical institutions. He graduated with a gold medal as the best outgoing student during his MD program, a distinction that reflects both academic commitment and clinical aptitude.
Prior to joining Zulekha Hospital Dubai, he worked at HCG Cancer Centre (HealthCare Global Enterprises Ltd.), one of India's largest oncology hospital networks. This gave him broad exposure to solid tumours, haematological malignancies, stem cell transplantation, and immunotherapy. He has also served as a principal investigator on multiple Phase II and Phase III clinical trials across hepatocellular carcinoma, lung cancer, colorectal cancer, and head and neck malignancies.
For those seeking the best oncologist in Dubai, Dr. Ponnada offers a genuinely well-rounded practice covering breast, gastrointestinal, thoracic, genitourinary, gynecological, and paediatric cancers, as well as immune-oncology and preventive oncology.
Educational Qualifications
● MBBS
● MD in Internal Medicine (Gold Medal, Best Outgoing Student)
● DM in Medical Oncology, Amrita Institute of Medical Sciences, Kerala, India
Special Interests
● Breast Cancer
● Gynecological malignancies
● Gastrointestinal malignancies
● Hematological malignancies
● Thoracic malignancies
● Genitourinary malignancies
● Pediatric malignancies
● Head and neck malignancies
● Autologous stem cell transplantation
● Immune-oncology and preventive oncology.
Research / Publications
● The value of low, fixed, single-dose rasburicase in the prevention and treatment of tumour lysis syndrome. JCO, 2019.
● A prospective study on the impact of chemotherapy-related toxicities on quality of life in elderly cancer patients. JCO, 2019.
● Rising thyroid cancer incidence in Kerala: real increase or overdiagnosis? JCO, 2019.
● Correlation of serum PIVKA-II and AFP with portal vein tumour thrombus and BCLC stage in newly diagnosed hepatocellular carcinoma. JCO, 2020.
FAQs
He manages a wide range of cancers including breast, colorectal, lung, liver, haematological, gynecological, genitourinary, head and neck, and paediatric malignancies.
It is a procedure where a patient's own stem cells are collected, stored, and reinfused after high-dose chemotherapy. It is primarily used in certain haematological cancers. Dr. Ponnada has experience in this area.
Yes. He has served as a principal investigator on multiple Phase II and Phase III trials across hepatocellular carcinoma, lung cancer, colorectal cancer, and head and neck cancer.
Yes. Immuno-oncology is part of his practice, and he keeps current with developments in cancer immunotherapy to offer evidence-based treatment options.
He is fluent in English, Malayalam, Telugu, and Hindi.